Effects of liver disease on the disposition of the opioid antagonist nalmefene

R. Frye,G. Matzke,R. Schade,R. Dixon,M. Rabinovitz
DOI: https://doi.org/10.1016/S0009-9236(97)90178-8
1997-01-01
Clinical pharmacology and therapy
Abstract:
What problem does this paper attempt to address?